Humana Inc. (NYSE:HUM) Shares Sold by Prudential PLC

Key Points

• Prudential PLC decreased its holdings in Humana Inc. (NYSE:HUM) by 56.7%, now owning 4,042 shares worth approximately $1.07 million.
• Vanguard Group Inc. increased its stake in Humana by 8.9%, now holding nearly 14 million shares valued at around $3.7 billion.
• Humana reported $6.27 earnings per share for the last quarter, missing estimates, with revenue increasing 9.6% year-over-year to $32.39 billion.

Prudential PLC trimmed its position in Humana Inc. (NYSE:HUM - Free Report) by 56.7% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,042 shares of the insurance provider's stock after selling 5,290 shares during the period. Prudential PLC's holdings in Humana were worth $1,070,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of HUM. Vanguard Group Inc. grew its stake in Humana by 8.9% in the first quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider's stock worth $3,697,222,000 after purchasing an additional 1,143,662 shares in the last quarter. GAMMA Investing LLC grew its stake in Humana by 40,881.1% in the first quarter. GAMMA Investing LLC now owns 781,099 shares of the insurance provider's stock worth $2,066,790,000 after purchasing an additional 779,193 shares in the last quarter. Southpoint Capital Advisors LP acquired a new position in Humana in the fourth quarter worth about $190,282,000. Nuveen LLC acquired a new position in Humana in the first quarter worth about $171,220,000. Finally, 8 Knots Management LLC acquired a new position in Humana in the fourth quarter worth about $145,258,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Price Performance

Shares of NYSE:HUM opened at $286.73 on Friday. Humana Inc. has a 12 month low of $206.87 and a 12 month high of $382.72. The stock has a market cap of $34.49 billion, a price-to-earnings ratio of 22.01, a PEG ratio of 1.65 and a beta of 0.44. The stock's 50 day moving average price is $242.70 and its 200 day moving average price is $253.82. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). The business had revenue of $32.39 billion during the quarter, compared to analyst estimates of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%. The company's quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter last year, the firm posted $6.96 EPS. Equities research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on HUM. Raymond James Financial raised shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 target price on the stock in a report on Thursday, May 1st. Wall Street Zen cut shares of Humana from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Robert W. Baird cut their target price on shares of Humana from $300.00 to $297.00 and set a "neutral" rating on the stock in a report on Friday, July 25th. Bank of America cut their target price on shares of Humana from $320.00 to $260.00 and set a "neutral" rating on the stock in a report on Tuesday, June 17th. Finally, Argus reissued a "hold" rating and issued a $281.99 target price on shares of Humana in a report on Thursday. Eighteen investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and an average target price of $281.45.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.